Biomea Fusion Financials
| BMEA Stock | USD 6.38 0.10 1.59% |
Biomea |
Understanding current and past Biomea Fusion Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biomea Fusion's financial statements are interrelated, with each one affecting the others. For example, an increase in Biomea Fusion's assets may result in an increase in income on the income statement.
Please note, the presentation of Biomea Fusion's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomea Fusion's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomea Fusion's management manipulating its earnings.
Biomea Fusion Stock Summary
Biomea Fusion competes with Edgewise Therapeutics, Werewolf Therapeutics, Cullinan Oncology, Design Therapeutics, and Ikena Oncology. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The company was incorporated in 2017 and is headquartered in Redwood City, California. Biomea Fusion operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US09077A1060 |
| CUSIP | 09077A106 |
| Location | California; U.S.A |
| Business Address | 900 Middlefield Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | biomeafusion.com |
| Phone | 650 980 9099 |
| Currency | USD - US Dollar |
Biomea Fusion Key Financial Ratios
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.56 | ||||
| Target Price | 42.89 | ||||
| Number Of Employees | 107 | ||||
| Beta | -0.43 |
Biomea Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomea Fusion's current stock value. Our valuation model uses many indicators to compare Biomea Fusion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomea Fusion competition to find correlations between indicators driving Biomea Fusion's intrinsic value. More Info.Biomea Fusion is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomea Fusion's earnings, one of the primary drivers of an investment's value.Biomea Fusion Systematic Risk
Biomea Fusion's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biomea Fusion volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Biomea Fusion correlated with the market. If Beta is less than 0 Biomea Fusion generally moves in the opposite direction as compared to the market. If Biomea Fusion Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biomea Fusion is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biomea Fusion is generally in the same direction as the market. If Beta > 1 Biomea Fusion moves generally in the same direction as, but more than the movement of the benchmark.
About Biomea Fusion Financials
What exactly are Biomea Fusion Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biomea Fusion's income statement, its balance sheet, and the statement of cash flows. Potential Biomea Fusion investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biomea Fusion investors may use each financial statement separately, they are all related. The changes in Biomea Fusion's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomea Fusion's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Biomea Fusion November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biomea Fusion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biomea Fusion. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomea Fusion based on widely used predictive technical indicators. In general, we focus on analyzing Biomea Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomea Fusion's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 24.44 | |||
| Value At Risk | (8.16) | |||
| Potential Upside | 9.12 |
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |